---
title: "FRKJ released its first-quarter performance, with a net profit attributable to the parent company of 20.6216 million yuan, a year-on-year decrease of 67.38%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237424072.md"
description: "FRKJ released its Q1 2025 performance report, with operating revenue of 561 million yuan, a year-on-year increase of 17.32%. However, the net profit attributable to shareholders of the listed company was 20.6216 million yuan, a year-on-year decrease of 67.38%; the net profit after deducting non-recurring gains and losses was 16.8035 million yuan, a year-on-year decrease of 60.42%. The basic earnings per share were 0.0268 yuan/share"
datetime: "2025-04-24T15:34:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237424072.md)
  - [en](https://longbridge.com/en/news/237424072.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237424072.md)
generator: "portal-rs"
---

# FRKJ released its first-quarter performance, with a net profit attributable to the parent company of 20.6216 million yuan, a year-on-year decrease of 67.38%

According to the Zhitong Finance APP, FRKJ (603327.SH) released its first-quarter report for 2025. The company's first-quarter operating revenue was 561 million yuan, a year-on-year increase of 17.32%; the net profit attributable to shareholders of the listed company was 20.6216 million yuan, a year-on-year decrease of 67.38%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 16.8035 million yuan, a year-on-year decrease of 60.42%; basic earnings per share were 0.0268 yuan/share

### Related Stocks

- [603327.CN](https://longbridge.com/en/quote/603327.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Jiangsu Expressway schedules interim results presentation via telephone video conference](https://longbridge.com/en/news/296498702.md)
- [KINGSOFT  Interim Net Profit Up 100.8% YoY to RMB1.639 Billion; No Interim Dividend](https://longbridge.com/en/news/296417569.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**